These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26766493)

  • 21. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
    Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
    Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z; Yuan S; Hao J; Fang X
    Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mahanimbine isolated from Murraya koenigii inhibits P-glycoprotein involved in lung cancer chemoresistance.
    Mondal P; Natesh J; Abdul Salam AA; Meeran SM
    Bioorg Chem; 2022 Dec; 129():106170. PubMed ID: 36174443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
    Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
    Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers.
    Pires MM; Emmert D; Hrycyna CA; Chmielewski J
    Mol Pharmacol; 2009 Jan; 75(1):92-100. PubMed ID: 18945821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein.
    Horton JK; Thimmaiah KN; Altenberg GA; Castro AF; Germain GS; Gowda GK; Houghton PJ
    Mol Pharmacol; 1997 Dec; 52(6):948-57. PubMed ID: 9415704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport.
    Liao ZG; Tang T; Guan XJ; Dong W; Zhang J; Zhao GW; Yang M; Liang XL
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27886150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged inhibition of P-glycoprotein after exposure to chemotherapeutics increases cell mortality in multidrug resistant cultured cancer cells.
    Nanayakkara AK; Vogel PD; Wise JG
    PLoS One; 2019; 14(6):e0217940. PubMed ID: 31173617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.
    Chan KF; Wong IL; Kan JW; Yan CS; Chow LM; Chan TH
    J Med Chem; 2012 Mar; 55(5):1999-2014. PubMed ID: 22320402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical mechanism of modulation of human P-glycoprotein by stemofoline.
    Chanmahasathien W; Ohnuma S; Ambudkar SV; Limtrakul P
    Planta Med; 2011 Dec; 77(18):1990-5. PubMed ID: 21786221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance.
    Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P
    Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
    Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
    Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias.
    O'Connor R; Ooi MG; Meiller J; Jakubikova J; Klippel S; Delmore J; Richardson P; Anderson K; Clynes M; Mitsiades CS; O'Gorman P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1357-68. PubMed ID: 23589314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B; Chai S; Li N; To KK; Kan WL; Yang D; Lin G
    Int J Pharm; 2012 Mar; 424(1-2):33-9. PubMed ID: 22226881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.